baber/WOPTO huggingface dataset:
Patent AU-2019272036-A1 (AU)
Title: Integrated thermal comfort control system utilizing circulating fans
Inventor: SARKISIAN DYLAN
IPC: F04D25/08
Filed: 2019-11-29
Abstract: Abstract A system for providing thermal comfort for a person within a space comprising a plurality of interconnected zones, such as a single room in a residence, commercial 5 establishment, or industrial location. At least one fan is positioned in each zone, which may be an overhead fan mounted to a ceiling common to two or more of the zones, and a sensor is provided for sensing a condition in at least one of the zones. A controller is adapted for controlling the fan in the at least one zone independent of another fan based on the sensed condition in the at least one zone including the controlled fan. Related aspects of a thermal 10 comfort control system and methods are also disclosed.
Patent AU-2019280089-A1 (AU)
Title: An adaptable mortice lock, a mortice lock kit and a method for mounting to a door an adaptable mortice lock
Inventor: BUTT SIMON JAMES
IPC: E05B63/00
Filed: 2019-12-13
Abstract: Disclosed herein is an adaptable mortice lock, a mortice lock kit and a method for mounting to a 
door an adaptable mortice lock.
1/4 
LO 
LI, 
mm 
to 
C' 
Un 
U-4
Patent AU-2019282098-A1 (AU)
Title: Pyrazolopyrimidine compounds as adenosine receptor antagonists
Inventor: BELL ANDREW SIMON
IPC: A61K31/505
Filed: 2019-06-04
Abstract: The invention provides a compound of formula (I), or pharmaceutically acceptable ester, amide, carbamate, solvate or salt thereof, including a salt of such an ester, amide or carbamate, (I) wherein R
Patent AU-2019283980-A1 (AU)
Title: Landing pad for unmanned aerial vehicle delivery
Inventor: WALSH RYAN
IPC: A47G29/14
Filed: 2019-12-20
Abstract: LANDING PAD FOR UNMANNED AERIAL VEHICLE DELIVERY A landing pad (1) comprising: a landing platform (2); a storage compartment (3); and a receiver associated with said landing pad (1) capable of receiving a first signal.
Patent AU-2019312814-A1 (AU)
Title: CYSDV resistance in members of the cucurbitaceae family
Inventor: DE GRAAG PAUL
IPC: C12N15/29
Filed: 2019-07-30
Abstract: The present invention relates to a modified gene that provides resistance to Cucurbit Yellow Stunting Disorder virus (CYSDV) when present in a plant of the
Patent AU-2019327295-A1 (AU)
Title: A valve for closing fluid communication between a well and a production string, and a method of using the valve
Inventor: KILLIE RUNE
IPC: E21B34/08
Filed: 2019-08-16
Abstract: A valve (1) for closing fluid communication between a horizontal or deviated well (W) and a production string (PS) when a content of a first or a second undesired fluid in the fluid flow exceeds a pre-determined level, the valve (1) comprising a primary flow channel (3), a piston arrangement (20) movable within the valve (1) between an inactive position allowing fluid flow through the primary channel and an active position preventing fluid flow through the primary channel, the piston arrangement further comprises a secondary flow channel and a bypass flow channel, wherein the valve (1) further comprising inflow control elements (30, 30') exposed to the fluid flow upstream of the flow barrier (7) and having different density and movable within independent paths (32, 32') in response to a density of fluid.
Patent AU-2019364415-A1 (AU)
Title: ALK2 antibodies and methods of use thereof
Inventor: SEEHRA JASBIR S
IPC: A61K39/395
Filed: 2019-10-23
Abstract: The invention features ALK2 antibodies and antigen binding fragments thereof (e.g., ALK2 binding fragments). The invention also features pharmaceutical compositions and methods of using the ALK2 antibodies or antigen binding fragments thereof to treat bone disease or damage, low red blood cell levels (e.g., anemia or blood loss), heterotopic ossification (e.g., heterotopic ossification resulting from fibrodysplasia ossificans progressiva), Sjogren's syndrome (e.g., dry eye associated with Sjogren's syndrome), multiple osteochondroma, diffuse intrinsic pontine glioma, posterior capsule opacification, or cardiac hypertrophy and/or cardiac fibrosis.
Patent AU-2019378019-A1 (AU)
Title: Real-time motion monitoring using deep neural network
Inventor: BÈRIAULT SILVAIN
IPC: G06T7/246
Filed: 2019-11-14
Abstract: Systems and techniques may be used to estimate a relative motion of patient anatomy using a deep learning network during a radiotherapy treatment. For example, a method may include using a first deep neural network to relate input real-time partial patient measurements and a patient model including a reference volume to output patient states. The method may include using a second deep neural network to relate the patient states and the reference volume to relative motion information between the patient states and the reference volume. The deep neural networks may be used in real time to estimate a relative motion corresponding to an input image.
Patent WO-2021026614-A1 (WO)
Inventor: KWARCINSKI JEREMY
IPC: B65D85/50
Filed: 2020-08-14
Abstract: A medical device for thermally insulating a graft to be transplanted includes a cover body or receptacle. The cover body includes a cavity within which the graft is received, in use. The cover body is made of a biocompatible thermally insulating material. The cover body has a shape similar to that of the graft. In use, the medical device is configured to keep the graft received therein sufficiently cool to substantially prevent warm ischaemic injury to the graft.
Patent WO-2021155422-A1 (WO)
Title: A system and method for detecting airborne pathogens
Inventor: NAUMOVSKI STEVE
IPC: B01L3/00
Filed: 2020-11-30
Abstract: The present invention relates to a system for detecting airborne pathogens. The system comprises a pathogen collector having a surface area for engaging with pathogens and an electrochemical sensor for electrochemically detecting pathogens accumulated on the surface area of the pathogen collector. The system is configured such that an air flow is generated that moves pathogens within ambient air towards and/or along the surface area of the pathogen collector such that pathogens can engage and accumulate on the surface area. The reactive substance of the electrochemical sensor electrochemically reacts with the pathogens and in response to the electrochemical reaction the electrode of the electrochemical sensor detects an electronic signal, wherein the electronic signal is indicative of the presence of pathogens accumulated on the pathogen collector.
Patent AU-2020202474-A1 (AU)
Title: A gaming management system and gaming management method
Inventor: BOESEN JOHN LESLIE
IPC: G06Q50/00
Filed: 2020-04-09
Abstract: A gaming management system comprising: a plurality of gaming management clients each 5 associated with at least one of a plurality of venues, each gaming management client being arranged such that gaming management data associated with a respective venue and received from electronic gaming machines is buffered at the gaming management client; 10 at least one display separate to the electronic gaming machines at at least one of the plurality of venues; a gaming management server in communication with the plurality of gaming management clients, the gaming 15 management server being adapted to store the gaming management data for each venue and comprising a data access module arranged to control access to the gaming management data by each gaming management client so that a gaming management client can only access gaming management 20 data of a venue with which the gaming management client is associated, the gaming management server further comprising a jackpot controller operable to provide a progressive jackpot at a respective one of the plurality of venues, and wherein the gaming management server 25 controls setting of the at least one display; and a local database in communication with a respective one of the plurality of gaming management clients, the local database being adapted to store the buffered gaming management data locally, and being arranged to 30 periodically synchronise with the gaming management server via the gaming management client, such that if the gaming management server goes offline, the gaming management client can employ the most recent version of the gaming management data. 12268211_1 (GHMaes) P76936.AU.6
Patent AU-2020202663-A1 (AU)
Title: Seat positioning system for a wheelchair
Inventor: MULHERN JAMES
IPC: A61G5/10
Filed: 2020-04-21
Abstract: A seat positioning system includes a base frame having a pair of forward slots and a pair of rear slots and a seat frame having a front end and a back end opposite the front end. The seat frame is coupled to the base frame and movable relative to the base frame. A first pair of linkages is slideably coupled to the pair of forward slots and connects the base frame to the seat frame. A first pair of locking devices has a locked configuration adapted to prevent the first pair of linkages from sliding relative to the pair of forward slots and an unlocked configuration adapted to allow the first pair of linkages to slide relative to the pair of forward slots. A second pair of linkages slideably is coupled to the pair of rear slots and connects the base frame to the seat frame. An actuator has a first end that is pivotally connected to the seat frame and a second end that is pivotally connected to the base frame. The actuator is configured to transition between an extended state and a contracted state to move the seat frame relative to the base frame. M co ry) 0 C) 0 ry) C) C) ry) r4 ry) r'4 r'4 r'4 r4 r4 ---------- 110 r4 r'4 r4 r'4 r'4 C) r4 ry) r'4
Patent AU-2020203096-A1 (AU)
Title: Sterile adapter control system and communication interface for use in a robotic surgical system
Inventor: SCHEIB CHARLES J
IPC: A61B17/00
Filed: 2020-05-11
Abstract: A robotic surgical system having a tool driver with a first housing and at least one rotatable output drive. The first housing is configured to attach to a surgical tool via a sterile adapter. The first housing has at least one projection extending from a surface of the first housing and is configured to bias away from the surface, the projection comprising at least one first surgical tool sensor configured to generate a sensor signal comprising at least one attachment state between the tool driver and the surgical tool based on a proximity of a first end of the projection relative to a second end of the projection. The at least one rotatable output drive is supported by the first housing and is configured to communicate torque to an input drive of the surgical tool through the sterile adapter.
Patent AU-2020203567-A1 (AU)
Title: Ambient sound enhancement and acoustic noise cancellation based on context
Inventor: WOODRUFF JOHN
IPC: H03G3/24
Filed: 2020-05-29
Abstract: An audio system has an ambient sound enhancement function, in which an 
against-the-ear audio device having a speaker converts a digitally processed version of an 
input audio signal into sound. The audio system also has an acoustic noise cancellation 
(ANC) function that may be combined in various ways with the sound enhancement 
function, and that may be responsive to voice activity detection. Other aspects are also 
described and claimed.
1/6 
CNJo 
Vi-i
Patent AU-2020207944-A1 (AU)
Title: Method and device for treating eye disease
Inventor: KAO BRANDON WEI-HSIANG
IPC: A61F9/007
Filed: 2020-01-17
Abstract: Described herein are devices used to treat high intraocular pressure and glaucoma.
Patent AU-2020219945-A1 (AU)
Title: Surface/submersible craft
Inventor: ALLEN GRAHAM
IPC: B63C11/46
Filed: 2020-02-07
Abstract: A surface/submersible water-craft (1), comprising: • a hull (102), • means for submerged propulsion provided in or on the hull, • means for surface propulsion provided in or on the hull, • floodable-on-submerging crew accommodation (106) provided in the hull and • a canopy (107) arranged for closing the floodable crew accommodation for protecting the crew from water flow past the craft, the canopy being openable for crew exit from the craft whilst submerged at a destination.
Patent AU-2020220214-A1 (AU)
Title: Tripeptide propylene oxide Derivative and preparation method and application thereof
Inventor: ZHU YONGQIANG
IPC: A61P35/00
Filed: 2020-01-03
Abstract: The present invention discloses a tripeptide propylene oxide derivative or a pharmaceutically 
acceptable salt thereof, and a preparation method and application thereof. The structure of the 
tripeptide propylene oxide derivative is shown in formula I. Compared with the prior art, the 
present invention provides tripeptide epoxy ketone compounds with a novel structure and a 
function of inhibiting proteasome. As 20S proteasome inhibitors, the tripeptide epoxy ketone 
compounds can block tumor cell proliferation and induce tumor cell apoptosis, so the tripeptide 
epoxy ketone compounds can be used for the treatment and prevention of a plurality of human and 
animal diseases such as malignant tumors, and the effect is significantly better.  
o R3  0 R1 
P N Z 
0 R2  0 
(I)
Patent AU-2020230275-A1 (AU)
Title: Mattress assembly and method
Inventor: ALLETTO JR EUGENE
IPC: A47C27/00
Filed: 2020-09-09
Abstract: A bedding system comprising: 
a chassis comprising a bottom wall, opposite first and second side walls 
extending upwardly from the bottom wall and opposite first and second end walls 
extending upwardly from the bottom wall, the walls defining a cavity; 
a cover covering outer surfaces of the side walls and the end walls; 
a spring pack positioned in the cavity, the spring pack comprising a plurality 
of springs; 
a barrier layer positioned over the spring pack, the barrier layer being attached 
to the cover by a first fastener; 
a topper positioned over the barrier layer, the topper being attached to the 
cover by a second fastener; and 
an outer layer positioned over the topper, the outer layer being attached to the cover 
by a third fastener.
Patent AU-2020256344-A1 (AU)
Title: Digital dynamic bias circuit
Inventor: PETROVIC BRANISLAV
IPC: H03F1/32
Filed: 2020-10-14
Abstract: Circuits and methods for reducing the cost and/or power consumption of a user terminal and/or the 
gateway of a telecommunications system that may include a telecommunications satellite. Embodi
ments generate a dynamic input bias signal based upon an information signal envelope (which may be 
pre-distorted) which is applied to the signal input of a power amplifier, thus reducing average power 
consumption. Other embodiments further include dynamic linearization of the information signal, 
and/or variation of the supply voltage to the power amplifier as a function of the envelope of the in
formation signal. Another aspect is a multi-stage "chained" feedback regulated voltage supply circuit 
for providing two or more output voltages that may be used as alternative supply voltages to a power 
amplifier.  
- 31 -
Patent AU-2020284117-A1 (AU)
Title: Fitness devices
Inventor: KISER ROLAND
IPC: A61H1/00
Filed: 2020-05-29
Abstract: A fitness device includes a base assembly, a table coupled to the base assembly, and a foot restraint coupled to the base assembly. The foot restraint is configured, responsive to a change in a relative position of the foot restraint with respect to the table, to apply a resistive force to at least one of one or more feet and one or more ankles of a user positioned in the fitness device. The fitness device may also include a controller that is configured to adjust at least one of (i) a height of the table utilizing one or more height actuators of the fitness device, and (ii) a rotation of the table utilizing one or more rotation actuators of the fitness device.
Patent AU-2020316495-A1 (AU)
Title: Humanized anti-VEGF Fab antibody fragment and use thereof
Inventor: XIE LIANGZHI
IPC: C07K16/22
Filed: 2020-07-17
Abstract: The present invention relates to the field of tumor immunotherapy, and relates to a humanized anti-VEGF Fab antibody fragment. Disclosed in the present invention are a nucleic acid sequence encoding the antibody fragment (comprising heavy/light chain variable regions), a vector containing the nucleic acid sequence, a pharmaceutical composition, and a kit. The anti-VEGF Fab antibody fragment disclosed in the present invention can be specifically bound to VEGF with high affinity, can block VEGF from binding to a receptor VEGFR2, and can also neutralize the proliferation effect of VEGF on HUVEC cells. Compared with the full-length structure, the antibody of the Fab fragment has stronger penetrability, and lower toxic and side effects such as gastrointestinal perforation, hypertension, and hemorrhage and cannot excite the complement cascade reaction, thereby reducing the risk of initiating intraocular inflammation and autoimmune inflammatory response. The antibody can be used to clinically treat various ocular diseases characterized by choroidal neovascularization, comprising but not limited to age-related macular degeneration (AMD), diabetic macular edema (DME), retinal edema, degenerative myopia, and choroidal neovascularization (CNV).
Patent AU-2020324275-A1 (AU)
Title: Refrigeration and/or liquefaction method, device and system
Inventor: GUILLET DAMIEN
IPC: F25B9/06
Filed: 2020-06-23
Abstract: Disclosed is a refrigeration and/or liquefaction method using a system that includes a low-temperature refrigeration device (1) comprising a working circuit (10) which forms a loop and contains a working fluid, the working circuit (10) forming a cycle comprising, connected in series: a compression mechanism (2, 3), a cooling mechanism (6), an expansion mechanism (7) and a heating mechanism (6, 8), the refrigeration device (1) further comprising a cooling exchanger (8) for extracting heat from the useful fluid stream by exchanging heat with the working fluid flowing in the working circuit (10), the system comprising a pipe (15) through which the useful fluid stream flows in the cooling exchanger (8), the method comprising a cooling step in which the refrigeration device (1) is in a first operating mode for cooling the cooling exchanger (8) while a useful fluid stream flows in the cooling exchanger (8), the method comprising, after said cooling step, a step of cleaning impurities that have solidified in the cooling exchanger (8), characterized in that during the cleaning step, the refrigeration device (1) is in a second operating mode in which the working gas flows in the working circuit (10) but in which the cooling exchanger (8) cools less intensely than in the first operating mode.
Patent AU-2020331921-A1 (AU)
Title: Device and method for application of cosmetic compositions through a grated end effector
Inventor: BINNER CURT
IPC: A61B5/00
Filed: 2020-08-13
Abstract: A device for applying a composition to a skin of a face includes an end effector having a base portion and a protruding portion extending distally from the base portion. The protruding portion has a distal opening. The device also includes a detector arrangement obtaining image data corresponding to an image of an area of the skin through the distal opening and an applicator arrangement applying the composition to a location within the area. The device further includes a processing arrangement receiving and analyzing the image data to determine whether the applicator is aimed to safely dispense the composition to the area and whether a frexel within the area corresponds to a skin artifact, and directing the applicator to selectively apply the composition to the frexel when the applicator is aimed to safely dispense the composition to the area and the skin artifact is detected from the frexel.
Patent AU-2020333427-A1 (AU)
Title: An improved combination cookware system
Inventor: BURRAGE CHRISTOPHER
IPC: A47J27/13
Filed: 2020-08-18
Abstract: The present disclosure relates to an improved combination cookware system having two components that can be used individually or coupled together so as to be used jointly.
Patent AU-2020336212-A1 (AU)
Title: Neurotoxin compositions for use in treating neurologic and psychiatric disorders
Inventor: BROOKS GREGORY F
IPC: A61K47/06
Filed: 2020-08-28
Abstract: Disclosed herein are compositions and methods for use in treating neurologic and psychiatric disorders.
Patent AU-2020361461-A1 (AU)
Title: Use of an anti-CCR7 antibody in combination therapies with a BTK inhibitor and/or Bcl2- inhibitor for treating hematological malignancies
Inventor: CUESTA MATEOS CARLOS
IPC: A61K31/519
Filed: 2020-10-09
Abstract: The present invention provides a novel use and methods comprising antibodies, or antigenbinding fragments thereof, which bind to a CCR7 receptor for use as a novel combination therapy with a BTK inhibitor and/or a Bcl-2 inhibitor in treatment of hyperproliferative blood malignancies, preferably in B-cell lymphomas, such as CLL. The combination can be used as first line, or in naïve patients not treated before with a BTK inhibitor and/or Bcl-2 inhibitor, or in patients with a BTK- inhibitor and/or Bcl-2-inhibior refractory/relapsed disease. The antibodies and antigen-binding fragments are capable of selectively depleting ex vivo or in vitro malignant cells expressing CCR7 and are capable of impairing/blocking migration of said tumor cells towards CCR7 ligands. These effects are not related to previous or contemporary treatments with a BTK inhibitor and/or a Bcl-2 inhibitor. Similarly, the efficacy of the antibodies is not affected in patients that have relapsed/refractory disease. The use of said antibodies as a monotherapy or as a combination with a BTK inhibitor and/or a Bcl-2 inhibitor for depleting, killing and impairing/blocking migration and activation of tumor cells expressing CCR7 cells is disclosed, thus providing an alternative therapy treating hyperproliferative blood cancers.
Patent AU-2020381037-A1 (AU)
Title: Method for culturing gynaecological tumour primary cells and matching culture medium
Inventor: ZHANG HANSHUO
IPC: C12N5/09
Filed: 2020-11-04
Abstract: Provided are a method for culturing gynaecological tumour primary cells and a matching reagent, the core of the technique being: using a gentle cell disassociation reagent to treat gynaecological solid tumour tissue to ensure the viability of the tumour cells in the tissue to the greatest possible extent; preparing a special serum-free medium, and using a suspension culture system to perform in vitro culture of the solid tumour cells from the gynaecological tumour source, eliminating the interference of normal cells to the greatest extent whilst ensuring the normal amplification of the tumour cells. The gynaecological tumour primary cell culture product obtained by the present method can be used in various cell-level in vitro experiments, second-generation sequencing, construction of animal models, and construction of cell lines. It can be predicted that the present culture method has wide prospects for application in the field of research and clinical diagnosis and treatment of gynaecological tumours.
Patent AU-2020387494-A1 (AU)
Title: 6-benzylidene-2-aryl ethynyl cyclohexenone derivatives, and preparation method therefor and medical use thereof
Inventor: LING YONG
IPC: A61P35/00
Filed: 2020-08-26
Abstract: Disclosed in the present invention are a class of 6-benzylidene-2-aryl ethynyl cyclohexenone derivatives and pharmaceutically acceptable salts thereof, preparation methods therefor, pharmaceutical compositions containing these derivatives, and the medical use thereof, in particular the use thereof in the preparation of drugs for treating malignant tumors. The compounds of the present invention have a certain tumor selectivity, can significantly inhibit tumor proliferation and have a weak inhibition effect on normal cells. The compounds of the present invention can significantly inhibit the activity of a TrxR target and induce an increase in the ROS level in tumor cells, thereby promoting the anti-tumor activity of the compounds of the present invention.